Analysts Just Shaved Their Tellgen Corporation (SZSE:300642) Forecasts Dramatically
The latest analyst coverage could presage a bad day for Tellgen Corporation (SZSE:300642), with the analysts making across-the-board cuts to their statutory estimates that might leave shareholders a l
The one-year shareholder returns and company earnings persist lower as Tellgen (SZSE:300642) stock falls a further 9.7% in past week
It's easy to match the overall market return by buying an index fund. Active investors aim to buy stocks that vastly outperform the market - but in the process, they risk under-performance. That dow
Three Days Left To Buy Tellgen Corporation (SZSE:300642) Before The Ex-Dividend Date
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be intrigued to know that Tellgen Corporation (SZSE:300642) is about to go ex-dividen
We Think That There Are More Issues For Tellgen (SZSE:300642) Than Just Sluggish Earnings
A lackluster earnings announcement from Tellgen Corporation (SZSE:300642) last week didn't sink the stock price. Our analysis suggests that along with soft profit numbers, investors should be aware
Downgrade: Here's How Analysts See Tellgen Corporation (SZSE:300642) Performing In The Near Term
The analysts covering Tellgen Corporation (SZSE:300642) delivered a dose of negativity to shareholders today, by making a substantial revision to their statutory forecasts for this year. Revenue an
The medical device sector fell, and 688606.CN fell 20.0%.
[Caihua Social News] at midday today, as of 13:15, the medical device plate fell. 688606.CN fell 20.00% to 175.84 yuan, 688075.CN fell 17.50% to 232.64 yuan, 688767.CN fell 16.69% to 102.06 yuan, 688068.CN fell 15.71% to 176.0 yuan, 688575.CN fell 14.33% to 38.98 yuan, 300482.CN fell 13.5%
The trading limit of January 11, 2022 already knew that the seven benefits are expected to be fermented.
January 10 news, there are seven good may affect tomorrow's stock market, specifically: Shanshui Bide: and fairy tale father, Huafu information signed a strategic cooperation agreement Shanshui Bide (300844) January 10 evening announcement, recently, the company and fairy tale dad, Huafu information signed a strategic cooperation agreement The parties plan to carry out strategic cooperation in various fields, including but not limited to metasmos science and technology, meta-cosmos theme parks, etc. Weifu Hi-Tech: plans to set up a hydrogen fuel cell parts joint venture company Weifu Hi-Tech (000581) announced on the evening of January 10th, the company and its subsidiary IRD intend to work with R.
Express delivery of evening announcement of listed companies on January 10
Sanda film: affected by the epidemic, the Xuchang fund-raising project was temporarily suspended on the evening of January 10 (688101). Recently, affected by COVID-19 's epidemic situation in Henan Province, the company's Xuchang fund-raising project base was temporarily suspended on January 10, 2022. Weifu Hi-Tech: plans to set up a hydrogen fuel cell parts joint venture company Weifu Hi-Tech (000581) announced on the evening of January 10th that the company and its subsidiary IRD intend to jointly invest 500 million yuan with RBINT and New Kinetic Fund to set up Wuxi Weifu hydrogen fuel Cell Technology Co., Ltd. Among them, the company
Review of the daily limit board: the contraction of the Prev index rebounded and rose 0.39%. More than 3000 stocks in the two markets rose.
January 10 news, the three major indices opened low after the bottom turned red, the index returned to 3100 points, once fell more than 1%, the plate, COVID-19 test plate higher, digital currency lower, meta-universe concept performance, salt lake lithium plate strong. In the afternoon, the three major indexes fell and turned green again, with northward capital inflows of nearly 9 billion yuan. in terms of plates, the concept of meta-universe rebounded and the real estate plate moved higher. Overall, the market as a whole is in a weak and volatile pattern, the long-short game is fierce, individual stocks rise more and fall less, and the money-making effect is general. By the end of the day, the Prev was up 0.39% at 3593.52 points, a deal.
Through the latest announcement of life: COVID-19 test kit medical device registration accepted
Tuojing life announcement, the company declared 2019-nCoV nucleic acid detection kit (card fluorescent PCR method) medical device registration was accepted. The chairman of the company is Yao Jianer. Mr. Yao Jianer: born in June 1970, Chinese nationality, no permanent residence abroad, master's degree, from June 1998 to June 2003, he served as the manager of the Pharmaceutical Research and Development Department of Shanghai Fudan Zhangjiang Biopharmaceutical Co., Ltd., the general manager of Shanghai Toujing Life Technology Co., Ltd from November 2003 to July 2011, and the director of Shanghai Tuojing Life Technology Co., Ltd from July 2011 to January 2015.